Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
Ronald S. Duman, Bhavya Voleti
Trends in Neurosciences (2012) Vol. 35, Iss. 1, pp. 47-56
Open Access | Times Cited: 668

Showing 1-25 of 668 citing articles:

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman, George K. Aghajanian, Gerard Sanacora, et al.
Nature Medicine (2016) Vol. 22, Iss. 3, pp. 238-249
Open Access | Times Cited: 1347
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman, George K. Aghajanian
Science (2012) Vol. 338, Iss. 6103, pp. 68-72
Open Access | Times Cited: 1316
The neurobiology of anhedonia and other reward-related deficits
Andre Der‐Avakian, Athina Markou
Trends in Neurosciences (2011) Vol. 35, Iss. 1, pp. 68-77
Open Access | Times Cited: 956
BDNF – a key transducer of antidepressant effects
Carl Björkholm, Lisa M. Monteggia
Neuropharmacology (2015) Vol. 102, pp. 72-79
Open Access | Times Cited: 825
The Effects of Psychological Stress on Depression
Longfei Yang, Yinghao Zhao, Yicun Wang, et al.
Current Neuropharmacology (2015) Vol. 13, Iss. 4, pp. 494-504
Open Access | Times Cited: 507
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon, Andrew H. Miller, Gerard Sanacora
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 193-215
Open Access | Times Cited: 444
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson, Peter S. Hendricks, Frederick S. Barrett, et al.
Pharmacology & Therapeutics (2018) Vol. 197, pp. 83-102
Closed Access | Times Cited: 420
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal, Gerard Sanacora, Ronald S. Duman
Biological Psychiatry (2013) Vol. 73, Iss. 12, pp. 1133-1141
Open Access | Times Cited: 378
mTOR in Brain Physiology and Pathologies
Joël Bockaert, Philippe Marin
Physiological Reviews (2015) Vol. 95, Iss. 4, pp. 1157-1187
Closed Access | Times Cited: 318
Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge, Allan H. Young, Anthony J. Cleare
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 1245-1262
Open Access | Times Cited: 318
Ketamine: 50 Years of Modulating the Mind
Linda Li, Phillip E. Vlisides
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 316
Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives
Corey Fee, Mounira Banasr, Etienne Sibille
Biological Psychiatry (2017) Vol. 82, Iss. 8, pp. 549-559
Open Access | Times Cited: 291
Synaptic plasticity in depression: Molecular, cellular and functional correlates
W.N. Marsden
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 43, pp. 168-184
Closed Access | Times Cited: 269
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle M. Gerhard, Eric S. Wohleb, Ronald S. Duman
Drug Discovery Today (2016) Vol. 21, Iss. 3, pp. 454-464
Open Access | Times Cited: 266
The role of the innate immune system in psychiatric disorders
Kenneth A. Jones, Christian Thomsen
Molecular and Cellular Neuroscience (2012) Vol. 53, pp. 52-62
Closed Access | Times Cited: 259
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Zezhi Li, Meihua Ruan, Jun Chen, et al.
Neuroscience Bulletin (2021) Vol. 37, Iss. 6, pp. 863-880
Open Access | Times Cited: 243
Sex differences in glutamate receptor gene expression in major depression and suicide
Aidan Gray, Thomas M. Hyde, Amy Deep–Soboslay, et al.
Molecular Psychiatry (2015) Vol. 20, Iss. 9, pp. 1057-1068
Open Access | Times Cited: 238
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections
Ronald S. Duman
Dialogues in Clinical Neuroscience (2014) Vol. 16, Iss. 1, pp. 11-27
Open Access | Times Cited: 234
Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior
Iva Lukić, Dmitriy Getselter, Ziv Oren, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus
Chelsea A. Vadnie, Colleen A. McClung
Neural Plasticity (2017) Vol. 2017, pp. 1-28
Open Access | Times Cited: 178
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Chadi G. Abdallah, Thomas G. Adams, Benjamin Kelmendi, et al.
Depression and Anxiety (2016) Vol. 33, Iss. 8, pp. 689-697
Open Access | Times Cited: 175
The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging
Laura M. Vecchio, Ying Meng, Kristiana Xhima, et al.
Brain Plasticity (2018) Vol. 4, Iss. 1, pp. 17-52
Open Access | Times Cited: 166
Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes
Mingrui Xia, Jin Liu, Andrea Mechelli, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 3, pp. 1384-1393
Closed Access | Times Cited: 138
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Yazen Alnefeesi, David Chen‐Li, Ella Krane, et al.
Journal of Psychiatric Research (2022) Vol. 151, pp. 693-709
Closed Access | Times Cited: 106
Depression and Its Phytopharmacotherapy—A Narrative Review
Łukasz Dobrek, Krystyna Głowacka
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4772-4772
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top